Invasive Fungal Disease in Allogeneic Hematopoietic Cell Transplantation: New Risk Factors and New Therapeutic Options in a Changing World

Documenti analoghi

• The Changing Epidemiology of Breakthrough Invasive Fungal Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the Era of Modified‐Release Posaconazole Prophylaxis
  di: Shio Yen Tio, et al.
  Pubblicazione: (2025)
• Clinical and Microbiological Insights Into Invasive Fusariosis Following Allogeneic Hematopoietic Stem Cell Transplantation: A 15‐Year Single‐Center Analysis
  di: Jotaro Yamamoto, et al.
  Pubblicazione: (2026)
• Reduction in Length of Hospital Stays for Allogeneic Hematopoietic Stem‐Cell Transplantation in the Letermovir Era
  di: Hiroki Hosoi, et al.
  Pubblicazione: (2025)
• Preventing Cat‐Astrophe: Toxoplasma Seroprevalence and Prophylaxis Adherence After Allogeneic Stem Cell Transplant
  di: Manogna Metlapalli, et al.
  Pubblicazione: (2026)
• Aspergillus versicolor Meningitis in a Patient With Refractory Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation
  di: Naonori Harada, et al.
  Pubblicazione: (2025)